In addition, answers are awaited as to whether tissue-specific regulatory HLA-E epitopes can be successfully mapped for the augmentation of tissue-specific HLA-E-restricted CD8+ Treg cells in humans and whether vaccination with tissue-specific regulatory HLA-E epitopes can be a novel therapy for human autoimmune diseases. This evidence concerns the gene CD8A and autoimmune disease.